Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
LeonaBio, Inc. (LONA) is the issuer named in a Schedule 13G reporting shared beneficial ownership of 393,700 common shares, or 4.2%, by Spruce Street Capital LP, Alex R. Rosen and Simon Basseyn. The filing says 9,421,663 common shares were outstanding as of August 12, 2026, the basis cited for the 4.2% figure. As of September 30, 2026, the reporting persons may have been deemed to beneficially own 1,033,464 shares, including 639,763 shares issuable under warrants. The warrants were subject to a 9.99% exercise blocker and expired unexercised on October 18, 2026. Spruce Street Capital Master Fund LP was identified as having the right to receive or direct dividends or sale proceeds from more than 5% of outstanding shares as of September 30, 2026.
Key Figures
Shared beneficial ownership:393,700 sharesReported ownership percentage:4.2%Potential beneficial ownership:1,033,464 shares+3 more
6 metrics
Shared beneficial ownership393,700 sharesReported by each reporting person; 4.2% of the class.
Reported ownership percentage4.2%Based on 9,421,663 common shares outstanding as of August 12, 2026.
Potential beneficial ownership1,033,464 sharesAs of September 30, 2026; the reporting persons may have been deemed to own this amount, including 639,763 shares issuable upon warrant exercise.
Warrant shares639,763 sharesIssuable upon exercise of warrants that expired unexercised on October 18, 2026.
Warrant exercise blocker9.99%Warrants were not exercisable to the extent exercise would result in beneficial ownership above this level.
Shares outstanding9,421,663 sharesAs of August 12, 2026; basis cited for the reported 4.2% ownership percentage.
Key Terms
beneficial ownership, 9.99% blocker, Warrants
3 terms
beneficial ownershipregulatory
"may have been deemed to beneficially own 1,033,464 shares"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
9.99% blockerregulatory
"Warrants described on the cover pages were subject to a 9.99% blocker"
Warrantsfinancial
"639,763 shares of Common Stock issuable upon exercise of warrants"
Warrants are special documents that give you the right to buy a company's stock at a set price before a certain date. They are often used as a way for companies to attract investors or raise money, and their value can increase if the company's stock price goes up.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many LONA shares did Spruce Street Capital report?
Spruce Street Capital LP, Alex R. Rosen and Simon Basseyn each reported shared voting and dispositive power over 393,700 LeonaBio common shares, representing 4.2% of the class. Each reporting person's cover page reports the same shared position.
How many warrant shares were included in the September 30, 2026 LONA ownership disclosure?
The reporting persons may have been deemed to beneficially own 1,033,464 shares, including 639,763 shares issuable upon warrant exercise. The warrants were subject to a 9.99% blocker and expired unexercised on October 18, 2026.
Which fund had dividend or sale-proceeds rights in LONA?
Spruce Street Capital Master Fund LP, a Spruce Street Fund, had the right to receive or direct dividends or proceeds from the sale of more than 5% of LeonaBio's outstanding common shares as of September 30, 2026.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
LeonaBio, Inc.
(Name of Issuer)
Common Stock, par value $0.0001 per share
(Title of Class of Securities)
04746L203
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
04746L203
1
Names of Reporting Persons
Spruce Street Capital LP
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
393,700.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
393,700.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
393,700.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.2 %
12
Type of Reporting Person (See Instructions)
IA, PN
Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the date hereof. As of September 30, 2026, the Reporting Persons may have been deemed to beneficially owned 1,033,464 shares of Common Stock (as defined below), including 639,763 shares of Common Stock issuable upon exercise of warrants (the "Warrants"). On October 18, 2026, the Warrants expired unexercised.
SCHEDULE 13G
CUSIP Number(s):
04746L203
1
Names of Reporting Persons
Alex R. Rosen
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
393,700.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
393,700.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
393,700.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.2 %
12
Type of Reporting Person (See Instructions)
HC, IN
Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the date hereof. As of September 30, 2026, the Reporting Persons may have been deemed to beneficially owned 1,033,464 shares of Common Stock, including 639,763 shares of Common Stock issuable upon exercise of warrants (the "Warrants"). On October 18, 2026, the Warrants expired unexercised.
SCHEDULE 13G
CUSIP Number(s):
04746L203
1
Names of Reporting Persons
Simon Basseyn
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
393,700.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
393,700.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
393,700.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
4.2 %
12
Type of Reporting Person (See Instructions)
HC, IN
Comment for Type of Reporting Person: The information set forth on this cover page reflects information as of the date hereof. As of September 30, 2026, the Reporting Persons may have been deemed to beneficially owned 1,033,464 shares of Common Stock, including 639,763 shares of Common Stock issuable upon exercise of warrants (the "Warrants"). On October 18, 2026, the Warrants expired unexercised.
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
LeonaBio, Inc.
(b)
Address of issuer's principal executive offices:
18706 NORTH CREEK PARKWAY, SUITE 104, BOTHELL, WA 98011
Item 2.
(a)
Name of person filing:
This statement is filed by:
(i) Spruce Street Capital LP (the "Investment Manager"), the investment manager to certain investment funds and/or accounts (collectively, the "Spruce Street Funds"), with respect to the shares of common stock, par value $0.0001 per share (the "Common Stock") of LeonaBio, Inc. (the "Company") held by the Spruce Street Funds;
(ii) Alex R. Ryan, co-Managing Member of Spruce Street Capital GP LLC, the general partner of the Investment Manager, and the co-Managing Partner of the Investment Manager, with respect to the shares of Common Stock held by the Spruce Street Funds; and
(iii) Simon Basseyn, co-Managing Member of Spruce Street Capital GP LLC, the general partner of the Investment Manager, and the co-Managing Partner of the Investment Manager, with respect to the shares of Common Stock held by the Spruce Street Funds.
The filing of this statement should not be construed as an admission that any of the forgoing persons or any Reporting Person is, for the purposes of Section 13 of the Act, the beneficial owner of the shares of Common Stock reported herein.
(b)
Address or principal business office or, if none, residence:
The address of the business office of each of the Reporting Persons is:
777 Third Avenue, Suite 1704
New York, New York 10017
(c)
Citizenship:
Citizenship is set forth in Row (4) of the cover page for each Reporting Person hereto and is incorporated herein by reference for each such Reporting Person.
(d)
Title of class of securities:
Common Stock, par value $0.0001 per share
(e)
CUSIP Number(s):
04746L203
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
The information required by Item 4(a) is set forth in Row (9) of the cover page for each of the Reporting Persons and is incorporated herein by reference.
The percentage set forth as of the date hereof in this Schedule 13G is calculated based upon an aggregate of 9,421,663 shares of Common Stock outstanding as of August 12, 2026, as reported in the Company's Quarterly Report on Form 10-Q, filed with the Securities and Exchange Commission on August 14, 2026.
As of September 30, 2026, the Reporting Persons may have been deemed to beneficially own 9.99% of the outstanding shares of Common Stock based upon an aggregate of 9,421,663 shares of Common Stock outstanding as of August 12, 2026, as reported in the Company's Quarterly Report on Form 10-Q for the quarterly period ended June 30, 2026, filed with the Securities and Exchange Commission on August 14, 2026. The Warrants described on the cover pages were subject to a 9.99% blocker whereby they were not exercisable to the extent that following such exercise, taking into account all other shares of Common Stock beneficially owned by the Reporting Persons, the Reporting Persons would beneficially own in excess of 9.99% of the outstanding Common Stock. On October 18, 2026, the Warrants expired unexercised.
(b)
Percent of class:
4.2%
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
The information required by Item 4(c)(i) is set forth in Row (5) of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(ii) Shared power to vote or to direct the vote:
The information required by Item 4(c)(ii) is set forth in Row (6) of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iii) Sole power to dispose or to direct the disposition of:
The information required by Item 4(c)(iii) is set forth in Row (7) of the cover page for each of the Reporting Persons and is incorporated herein by reference.
(iv) Shared power to dispose or to direct the disposition of:
The information required by Item 4(c)(iv) is set forth in Row (8) of the cover page for each of the Reporting Persons and is incorporated herein by reference.
Item 5.
Ownership of 5 Percent or Less of a Class.
Ownership of 5 percent or less of a class
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
As of the date hereof, not applicable. As of September 30, 2026, see Item 2(a) above; Spruce Street Capital Master Fund LP, a Spruce Street Fund, had the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, more than 5 percent of the outstanding shares of Common Stock.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.
Spruce Street Capital LP
Signature:
/s/ Alex R. Rosen
Name/Title:
Spruce Street Capital GP LLC, its General Partner, By: Alex R. Rosen, its Co-Managing Member